These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39370165)

  • 1. Prostate cancer survivorship of Australian men living with prostate cancer: Patient support programs in Australia.
    Ng Hung Shin B; Rhee H; Chung E
    Aust J Gen Pract; 2024 Oct; 53(10):773-776. PubMed ID: 39370165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study).
    Green A; Newton RU; Smith DP; Tuffaha H; Galvão DA; Heathcote P; Patel MI; Christie D; Egger S; Sara SA; Heneka N; Chambers SK; Dunn J
    BMJ Open; 2024 Mar; 14(3):e084412. PubMed ID: 38521521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of educational and psychological survivorship interventions to improve health-related quality of life outcomes for men with prostate cancer on androgen deprivation therapy: a systematic review.
    Sara SA; Heneka N; Green A; Chambers SK; Dunn J; Terry VR
    BMJ Open; 2024 May; 14(5):e080310. PubMed ID: 38777593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review.
    Edmunds K; Tuffaha H; Scuffham P; Galvão DA; Newton RU
    Support Care Cancer; 2020 Dec; 28(12):5661-5671. PubMed ID: 32699997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating a multicomponent survivorship programme for men with prostate cancer in Australia: a single cohort study.
    Yates P; Carter R; Cockerell R; Cowan D; Dixon C; Lal A; Newton RU; Hart N; Galvão DA; Baguley B; Denniston N; Skinner T; Couper J; Emery J; Frydenberg M; Liu WH
    BMJ Open; 2022 Feb; 12(2):e049802. PubMed ID: 35110307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea.
    Kang J; Shin DW; Han K; Park SH; Lee WG; Yoo JE; Woo SH; Park J
    Curr Probl Cancer; 2020 Dec; 44(6):100578. PubMed ID: 32360240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.
    Donovan KA; Walker LM; Wassersug RJ; Thompson LM; Robinson JW
    Cancer; 2015 Dec; 121(24):4286-99. PubMed ID: 26372364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
    Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
    BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
    Donovan KA; Gonzalez BD; Nelson AM; Fishman MN; Zachariah B; Jacobsen PB
    Psychooncology; 2018 Jan; 27(1):316-324. PubMed ID: 28557112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial.
    D'Amico AV; Xie W; McMahon E; Loffredo M; Medeiros S; Joseph D; Denham J; Kumar P; Bubley G; Sullivan M; Hellwig R; Carlos Vera J; Freter R; Jeffrey Baker W; Wong JY; Renshaw AA; Kantoff PW
    J Clin Oncol; 2021 Sep; 39(26):2938-2947. PubMed ID: 34197181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review.
    Edmunds K; Tuffaha H; Galvão DA; Scuffham P; Newton RU
    Support Care Cancer; 2020 May; 28(5):2079-2093. PubMed ID: 31912360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest in services among prostate cancer patients receiving androgen deprivation therapy.
    Shapiro PJ; Coyne JC; Kruus LK; Palmer SC; Vaughn DJ; Malkowicz SB
    Psychooncology; 2004 Aug; 13(8):512-25. PubMed ID: 15295773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.
    Deka R; Rose BS; Bryant AK; Sarkar RR; Nalawade V; McKay R; Murphy JD; Simpson DR
    Cancer; 2019 Apr; 125(7):1070-1080. PubMed ID: 30748008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of physically active men with prostate cancer on the role of physical activity in maintaining their quality of life: possible influence of androgen deprivation therapy.
    Keogh JW; Patel A; MacLeod RD; Masters J
    Psychooncology; 2013 Dec; 22(12):2869-75. PubMed ID: 23904113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study.
    Kao LT; Lin HC; Chung SD; Huang CY
    Asian J Androl; 2017; 19(4):414-417. PubMed ID: 27232853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juggling cancer and life in survivorship: The role of general practitioners.
    Hart NH; Smith AB; Hobbs K; Thamm C; Gordon LG; Crichton M; Chan RJ
    Aust J Gen Pract; 2021 Aug; 50(8):520-525. PubMed ID: 34333557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician.
    Siebert AL; Lapping-Carr L; Morgans AK
    Eur Urol Focus; 2020 Nov; 6(6):1170-1179. PubMed ID: 32690473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease.
    Keane FK; Chen MH; Zhang D; Moran BJ; Braccioforte MH; D'Amico AV
    Cancer; 2015 Aug; 121(16):2713-9. PubMed ID: 25925789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of Unmet Need and Access to Supportive Care for Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Bi-national Study.
    Paterson C; Primeau C; Howard N; Xiberras P; Pillay B; Crowe H
    Semin Oncol Nurs; 2020 Aug; 36(4):151049. PubMed ID: 32703715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoiding the 'survivorship abyss': Qualitative insights from 15-year prostate cancer survivors.
    Mazariego CG; Laidsaar-Powell R; Smith DP; Juraskova I
    Psychooncology; 2021 Oct; 30(10):1745-1755. PubMed ID: 34038008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.